机构:[1]Department of Pathology, Xuanwu Hospital Capital Medical University, Beijing, China病理科首都医科大学宣武医院[2]Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing, China[3]Department of Neurosurgery, Xuanwu Hospital Capital Medical University, Beijing, China神经外科首都医科大学宣武医院
Gliosarcoma, which is regarded as a variant of glioblastoma, is a rare malignant neoplasm of the central nervous system. Both its sarcomatous component and glial component are reported to share significant clinical and genetic similarities. However, gliosarcomas are considered to be characterised by a lack of the BRAF V600E mutation. Here, we report two cases of gliosarcoma harbouring the BRAF V600E mutation, of which one case appears to have arisen de novo, while the other likely arose from ganglioglioma. Interestingly, the BRAF V600E mutation was detected only in the glial component in the first case, but was present in both the glial and the sarcomatous components in the recurrent gliosarcoma. Furthermore, the different mutation state of BRAF V600E in our two cases suggests that the malignant transformation of gliosarcoma might have different underlying genetic alterations and mechanisms in de novo versus recurrent gliosarcoma.
基金:
Beijing Excellent Talent Training Project Grant (201600026833ZK07)
National Natural Science Foundation of China (81401040).
第一作者机构:[1]Department of Pathology, Xuanwu Hospital Capital Medical University, Beijing, China
通讯作者:
通讯机构:[*1]Department of Pathology, xuanwu hospital, Beijing, China
推荐引用方式(GB/T 7714):
Leiming Wang ,Jian Sun ,Zhuo Li ,et al.Gliosarcomas with the BRAF V600E mutation: a report of two cases and review of the literature[J].JOURNAL OF CLINICAL PATHOLOGY.2017,70(12):1079-1083.doi:10.1136/jclinpath-2017-204620.
APA:
Leiming Wang,,Jian Sun,,Zhuo Li,,Li Chen,,Yongjuan Fu,...&Dehong Lu.(2017).Gliosarcomas with the BRAF V600E mutation: a report of two cases and review of the literature.JOURNAL OF CLINICAL PATHOLOGY,70,(12)
MLA:
Leiming Wang,,et al."Gliosarcomas with the BRAF V600E mutation: a report of two cases and review of the literature".JOURNAL OF CLINICAL PATHOLOGY 70..12(2017):1079-1083